Resolution of Mycobacterium avium complex bacteremia following highly active antiretroviral therapy.
Hadad
D J
DJ
Division of Infectious and Parasitic Diseases, São Paulo Federal University, Brazil.
Lewi
D S
DS
Pignatari
A C
AC
Martins
M C
MC
Vitti Júnior
W
W
Arbeit
R D
RD
D017088:AIDS-Related Opportunistic Infections / Q000503:physiopathology / Q000517:prevention & control*; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000503:physiopathology / Q000517:prevention & control*; D016049:Didanosine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D008297:Male; D015270:Mycobacterium avium-intracellulare Infection / Q000503:physiopathology / Q000517:prevention & control*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D019469:Indinavir; D016049:Didanosine